Literature DB >> 23424256

A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management.

Kyla E Dunn1, Colleen Caleshu, Allison L Cirino, Carolyn Y Ho, Euan A Ashley.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23424256      PMCID： PMC3898734          DOI： 10.1161/CIRCGENETICS.110.959387

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN： 1942-3268


× No keyword cloud information.
  70 in total

Review 1.  Athlete"s heart and hypertrophic cardiomyopathy.

Authors:  A Pelliccia
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

2.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

3.  Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy.

Authors:  S F Nagueh; L L Bachinski; D Meyer; R Hill; W A Zoghbi; J W Tam; M A Quiñones; R Roberts; A J Marian
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

4.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

Authors:  D Fatkin; B K McConnell; J O Mudd; C Semsarian; I G Moskowitz; F J Schoen; M Giewat; C E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

5.  The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

Authors:  Christopher Semsarian; Imran Ahmad; Michael Giewat; Dimitrios Georgakopoulos; Joachim P Schmitt; Bradley K McConnell; Steven Reiken; Ulrike Mende; Andrew R Marks; David A Kass; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy.

Authors:  C Y Ho; H M Lever; R DeSanctis; C F Farver; J G Seidman; C E Seidman
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

7.  DNA sequencing: clinical applications of new DNA sequencing technologies.

Authors:  Frederick E Dewey; Stephen Pan; Matthew T Wheeler; Stephen R Quake; Euan A Ashley
Journal:  Circulation       Date:  2012-02-21       Impact factor: 29.690

8.  Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho; Nancy K Sweitzer; Barbara McDonough; Barry J Maron; Susan A Casey; J G Seidman; Christine E Seidman; Scott D Solomon
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

9.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.

Authors:  Ray E Hershberger; Joann Lindenfeld; Luisa Mestroni; Christine E Seidman; Matthew R G Taylor; Jeffrey A Towbin
Journal:  J Card Fail       Date:  2009-03       Impact factor: 5.712

10.  Phased whole-genome genetic risk in a family quartet using a major allele reference sequence.

Authors:  Frederick E Dewey; Rong Chen; Sergio P Cordero; Kelly E Ormond; Colleen Caleshu; Konrad J Karczewski; Michelle Whirl-Carrillo; Matthew T Wheeler; Joel T Dudley; Jake K Byrnes; Omar E Cornejo; Joshua W Knowles; Mark Woon; Katrin Sangkuhl; Li Gong; Caroline F Thorn; Joan M Hebert; Emidio Capriotti; Sean P David; Aleksandra Pavlovic; Anne West; Joseph V Thakuria; Madeleine P Ball; Alexander W Zaranek; Heidi L Rehm; George M Church; John S West; Carlos D Bustamante; Michael Snyder; Russ B Altman; Teri E Klein; Atul J Butte; Euan A Ashley
Journal:  PLoS Genet       Date:  2011-09-15       Impact factor: 5.917
View more
  12 in total

1.  Letter to the Editor: Contemporary Screening and Treatment of Hypertrophic Cardiomyopathy.

Authors:  Fahed Darmoch; Mohamad Soud; Yasser Al-Khadra; Homam Moussa Pacha; M Chadi Alraies
Journal:  Ochsner J       Date:  2018

Review 2.  Morphomechanic phenotypic variability of sarcomeric cardiomyopathies: A multifactorial polygenic perspective.

Authors:  Ares Pasipoularides
Journal:  J Mol Cell Cardiol       Date:  2018-11-10       Impact factor: 5.000

Review 3.  A Case for Inclusion of Genetic Counselors in Cardiac Care.

Authors:  Patricia Arscott; Colleen Caleshu; Katrina Kotzer; Sarah Kreykes; Teresa Kruisselbrink; Kate Orland; Christina Rigelsky; Emily Smith; Katherine Spoonamore; Joy Larsen Haidle; Monica Marvin; Michael J Ackerman; Azam Hadi; Arya Mani; Steven Ommen; Sara Cherny
Journal:  Cardiol Rev       Date:  2016 Mar-Apr       Impact factor: 2.644

4.  Provision of cardiovascular genetic counseling services: current practice and future directions.

Authors:  Allyson E Somers; Stephanie M Ware; Kathleen Collins; John L Jefferies; Hua He; Erin M Miller
Journal:  J Genet Couns       Date:  2014-05-01       Impact factor: 2.537

5.  Loperamide Toxicity Revealing Apical Hypertrophic Cardiomyopathy.

Authors:  Najah Khan; Kalyan R Chitturi; Courtney Hatcher; Marietta Clewing; Sherif F Nagueh
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-03-25

6.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  Heart Rhythm       Date:  2020-10-19       Impact factor: 6.343

7.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  J Arrhythm       Date:  2021-04-08

8.  Inpatient detection of cardiac-inherited disease: the impact of improving family history taking.

Authors:  Kathryn E Waddell-Smith; Tom Donoghue; Stephanie Oates; Amanda Graham; Jackie Crawford; Martin K Stiles; Andrew Aitken; Jonathan R Skinner
Journal:  Open Heart       Date:  2016-02-16

9.  Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Authors:  Keith Nykamp; Michael Anderson; Martin Powers; John Garcia; Blanca Herrera; Yuan-Yuan Ho; Yuya Kobayashi; Nila Patil; Janita Thusberg; Marjorie Westbrook; Scott Topper
Journal:  Genet Med       Date:  2017-05-11       Impact factor: 8.822

10.  Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes.

Authors:  Oscar Campuzano; Georgia Sarquella-Brugada; Anna Fernandez-Falgueras; Mónica Coll; Anna Iglesias; Carles Ferrer-Costa; Sergi Cesar; Elena Arbelo; Ana García-Álvarez; Paloma Jordà; Rocío Toro; Coloma Tiron de Llano; Simone Grassi; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  EBioMedicine       Date:  2020-04-05       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.